Advertising exemption: Panadol

Published in the Commonwealth of Australia Gazette No. GN 8, 28 February 2001

THERAPEUTIC GOODS ACT 1989

THERAPEUTIC GOODS REGULATIONS

I, PIO CESARIN, Acting Director, Chemicals & Non-prescription Medicines Branch, Therapeutic Goods Administration and delegate of the Secretary to the Department of Health and Aged Care for the purposes of Regulation 7C (1) of the Therapeutic Goods Regulations, give notice that the restricted representation described in paragraph (a) below, has been approved for use in advertisements directed to consumers, for the products listed in paragraph (b):

1. A representation to the effect that goods described in paragraph (b) below are:
   "Suitable for people with stomach ulcers".
2. PANADOL CLEAR paracetamol 500mg effervescent tablet strip pack AUST R 15509
   PANADOL paracetamol 500mg filmcoated tablet blister pack AUST R 13591
   PANADOL CAPLETS paracetamol 500mg filmcoated tablet blister pack AUST R 13590
   PANADOL GEL CAP paracetamol 500mg tablet blister pack AUST R 40932
   PANADOL paracetamol 500mg capsule blister pack AUST R 15480
   PANADOL paracetamol 500mg banded capsule blister pack AUST R 47532.

Dated this 19th day of February 2001

PIO CESARIN
Delegate of the Secretary to the Department of Health and Aged Care